Late-Breaking Sessions on COVID-19

These late-breaking scientific sessions will cover timely and novel research on the evolving COVID-19 pandemic. AACC will continue to add more sessions on this pressing topic as we get closer to the meeting, so be sure to check back here for updates.

32454 Antibody and Antigen Testing for SARS-CoV-2: Where Are We Now?

Monday, December 14
12:30 - 2 p.m.

The clinical utility of serologic testing for SARS-CoV-2 continues to evolve. This session will provide the latest information regarding the role of antibody testing and the performance characteristics of select assays, and will review appropriate result interpretation and the clinical significance of reported results. Additionally, the speakers will discuss the utility and performance characteristics of antigen detection assays for SARS-CoV-2. Learn more.

34234 Therapeutic Strategies for COVID-19 

Wednesday, December 16
2:30 - 5 p.m.

As COVID-19 became a global pandemic, healthcare providers scrambled to find therapies that could successfully manage symptoms and combat the novel virus. This session will discuss treatments that did and did not work, including novel and repurposed drugs and convalescent plasma therapy. Additionally, it will highlight the utility of respiratory therapy strategies including intubation, mechanical ventilation, high-flow nasal cannula, and helmet non-invasive ventilation. Learn more.

New Virtual Options Added to Live Meeting

We are excited to announce that AACC will provide a virtual platform in which select education sessions, access to exhibitors, and other networking events will be available.